e.g. Tata motors, Reliance MF, 500570

Krebs Biochemicals & Industries Ltd.

524518  KREBSBIO   Group (T)

30 Apr,10:00
60.12 2.86 (4.99%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
    Download App
BSE  |  NSE
zoomZoomRefresh
Day
Wk
Mn
6Mn
Yr
Volume

10

Prev close

57.26

Day's H/L (Rs.)

60.12 - 56.40

52wk H/L (Rs.)

113.90 - 38.52

Mkt Cap (Rs. Cr)

129.86

Krebs Biochemicals & Industries Ltd.

InvestChart

Krebs Biochemicals & Industries Ltd.

KREBSBIO

30 Apr,15:40
59.67 -0.33 (-0.55%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
    Download App
BSE  |  NSE
ZoomRefresh
Day
Wk
Mn
6Mn
Yr
Volume

500

Prev close

60.00

Day's H/L (Rs.)

59.85 - 57.40

52wk H/L (Rs.)

113.50 - 38.33

Turnover (Rs. Lacs)

29,790.00

Krebs Biochemicals & Industries Ltd.

InvestChart

Financial Results of Krebs Biochemicals & Industries Ltd.

(Rs. Crore)
Mar ' 25Mar ' 24Mar ' 23Mar ' 22Mar ' 21
Sales43.3150.4252.1352.9453.70
Operating profit-15.03-8.72-15.78-40.76-17.58
Interest5.914.692.975.396.28
Gross profit-20.23-12.96-18.13-38.23-23.23
EPS (Rs)-12.49-9.15-11.45-20.65-14.45

See More >

Compare 'Krebs Biochemicals & Industries Ltd.' with other stocks

  • Sai Life Science Ltd.
  • 1,055.15
  • Compare
  • Sun Pharmaceutical Industries Ltd.
  • 1,778.95
  • Compare
  • Divi's Laboratories Ltd.
  • 6,535.00
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 1,330.10
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 4,230.10
  • Compare
  • Zydus Lifesciences Ltd.
  • 910.40
  • Compare
  • Max Healthcare Institute Ltd.
  • 1,005.70
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 7,704.10
  • Compare

Statements:

Balance Sheet  |  P&L  |  Cash Flow  |  Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

Krebs Biochemicals & Industries Ltd. PERFORMANCE SNAPSHOT

If you had invested Rs.
in Krebs Biochemicals & Industries Ltd.,
  ago

You would have Rs. 000.00

Add to Portfolio

Report Card

PE Ratios
-4.81
EPS (Rs.)
-12.49
Sales (Rs. Cr)
7.27
Face Value (Rs.)
10
Net Profit Margin (%)
-62.19
Last Bonus
Last Dividend (%)
30
Return on Average Equity

Frequently Asked Questions

Q: What is the current share price of Krebs Biochemicals & Industries Ltd.?

A: The current share price of Krebs Biochemicals & Industries Ltd. is ₹ 60.12 (for BSE as on 30 Apr,10:00). The 52-week range is ₹ 113.90 - 38.52. Prices are updated based on live market data.

Q: What is the market capitalization of Krebs Biochemicals & Industries Ltd.?

A: Krebs Biochemicals & Industries Ltd. has a market capitalization of ₹ 129.86 Cr, making it a company.

Q: What is the PE ratio of Krebs Biochemicals & Industries Ltd.?

A: The Price-to-Earnings (PE) ratio of Krebs Biochemicals & Industries Ltd. is -4.81, indicating its valuation relative to earnings.

Q: Is Krebs Biochemicals & Industries Ltd. a good investment?

A: Krebs Biochemicals & Industries Ltd. is considered based on its financial performance, sector outlook, and market conditions. Investors should evaluate fundamentals and consult financial advisors before investing.

Q: Does Krebs Biochemicals & Industries Ltd. pay dividends?

A: Yes. Krebs Biochemicals & Industries Ltd. pay dividends. The latest dividend yield is 30%.

Q: What are the latest financial results of Krebs Biochemicals & Industries Ltd.?

A: Krebs Biochemicals & Industries Ltd. has reported its latest annual results with revenue of ₹ 43.31 and net profit/loss of ₹ -26.94.

Close
Add Krebs Biochemicals & Industries Ltd. to your Portfolio
 
 
     
 
Close
Add Krebs Biochemicals & Industries Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback